Zhu Yue, Guan Linbo, Fan Ping, Liu Rui, Wei Xing, Liu Yu, Bai Huai
Laboratory of Genetic Disease and Perinatal Medicine, West China Second Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Jun 10;35(3):408-413. doi: 10.3760/cma.j.issn.1003-9406.2018.03.023.
To investigate effects of GSTM1 and GSTT1 gene polymorphisms on serum lipid and apopoprotein levels in healthy normolipidemic and endogenous hypertriglyceridemic subjects.
Two hundred and thirty-seven healthy normolipidemic and 102 endogenous hypertriglyceridemic subjects from a population of Chinese Han nationality in Chengdu area were studied using the multiplex polymerase chain reaction (PCR). Serum lipids were measured by enzymatic kits and apolipoproteins AⅠ, AⅡ, B100, CⅡ, CⅢ and E were measured by the RID kits.
The non-null and null genotype frequencies for GSTM1 site were 39.2% and 60.8% in the control group, respectively, and 47.6% and 52.4% in the HTG group, respectively. The non-null and null genotype frequencies for GSTT1 site were 51.5% and 48.5% in the control group, respectively, and 57.3% and 42.7% in the HTG group, respectively. The GSTM1 and GSTT1 genotype frequencies in HTG subjects were not different from those in the controls, respectively (P>0.05). However, in control group subjects with both null genotypes (GSTT1- and GSTM1-) showed the lowest plasma HDL-C levels (1.29±0.30 mmol/L), whereas those with each of the other three genotype combinations showed relatively higher HDL-C levels. There was significant difference of HDL-C levels between subjects with GSTT1-/GSTM1-and those with GSTT1+/GSTM1-(P<0.05). Similar result was not observed in HTG group. No significant changes of lipid and lipoprotein levels were observed in either GSTM1 or GSTT1 polymorphism alone in control or HTG group.
The present study provides an evidence that the presence of double deletion genotypes is associated with low HDL-cholesterol levels in normal Chinese subjects. However, these polymorphisms are not associated with lipid levels in endogenous hypertriglyceridemia in Chinese population of Chengdu area.
研究谷胱甘肽硫转移酶M1(GSTM1)和谷胱甘肽硫转移酶T1(GSTT1)基因多态性对健康血脂正常者及内源性高甘油三酯血症患者血脂及载脂蛋白水平的影响。
采用多重聚合酶链反应(PCR)对成都地区237名健康血脂正常者及102名内源性高甘油三酯血症汉族人群进行研究。采用酶试剂盒检测血脂,采用免疫比浊法试剂盒检测载脂蛋白AⅠ、AⅡ、B100、CⅡ、CⅢ和E。
GSTM1位点非缺失和缺失基因型频率在对照组分别为39.2%和60.8%,在高甘油三酯血症(HTG)组分别为47.6%和52.4%。GSTT1位点非缺失和缺失基因型频率在对照组分别为51.5%和48.5%,在HTG组分别为57.3%和42.7%。HTG组中GSTM1和GSTT1基因型频率与对照组相比,差异无统计学意义(P>0.05)。然而,在对照组中,同时具有两种缺失基因型(GSTT1-和GSTM1-)的受试者血浆高密度脂蛋白胆固醇(HDL-C)水平最低(1.29±0.30 mmol/L),而其他三种基因型组合的受试者HDL-C水平相对较高。GSTT1-/GSTM1-的受试者与GSTT1+/GSTM1-的受试者之间HDL-C水平差异有统计学意义(P<0.05)。HTG组未观察到类似结果。在对照组或HTG组中,单独的GSTM1或GSTT1基因多态性均未观察到血脂和脂蛋白水平的显著变化。
本研究提供了证据表明双缺失基因型的存在与正常中国受试者低HDL-胆固醇水平相关。然而,这些多态性与成都地区中国人群内源性高甘油三酯血症的血脂水平无关。